Ownership
Private
Employees
~18
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved

i2Vision General Information

i2Vision is an active, independent healthcare communications and medical marketing agency specializing in translating complex science into clear, impactful messaging for biopharma, medtech, and healthcare clients. The company is particularly recognized for its expertise in ophthalmology but has expanded to serve multiple therapeutic areas. It provides strategic medical communications, scientific content development, KOL engagement, regulatory-compliant strategies, brand development, creative digital services, and event planning. In recent years it has experienced significant growth through new client acquisitions and expanded AOR (Agency of Record) relationships with leading biotech and pharma companies.

Contact Information

Primary Industry
Consulting
Corporate Office
San Diego, California
United States

Drug Pipeline

No pipeline data available

For full access to i2Vision's pipeline data

Book a demo

Key Partnerships

Astellas, Nanoscope Therapeutics, RevOpsis, Aviceda Therapeutics, Alkeus Pharmaceuticals, RegenxBio, Tarsus Pharmaceuticals, Bionic Vision Technologies

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

i2Vision Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view i2Vision's complete valuation and funding history, request access »

i2Vision Financial Metrics